These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23676345)

  • 1. Low-dose manic switch and high-dose antimanic effect and extrapyramidal symptoms by aripiprazole in a single bipolar patient.
    Park YM
    Am J Ther; 2014; 21(6):e218-20. PubMed ID: 23676345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group.
    De Fazio P; Girardi P; Maina G; Mauri MC; Mauri M; Monteleone P; Perini GI; Perugi G; Rossi A
    Clin Drug Investig; 2010; 30(12):827-841. PubMed ID: 20923242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination treatment with aripiprazole and valproic acid for acute mania: an 8-week, single-blind, randomized controlled trial.
    Jeong HG; Lee MS; Ko YH; Han C; Jung IK
    Clin Neuropharmacol; 2012; 35(3):97-102. PubMed ID: 22592508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole-induced movement disorder.
    Zacher JL; Hatchett AD
    Am J Psychiatry; 2006 Jan; 163(1):160-1. PubMed ID: 16390909
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of aripiprazole and tardive dyskinesia.
    Abbasian C; Power P
    J Psychopharmacol; 2009 Mar; 23(2):214-5. PubMed ID: 18515468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder.
    Wu WY; Chan HY; Tan HK
    Acta Neuropsychiatr; 2014 Feb; 26(1):61-4. PubMed ID: 25142102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance.
    Goodwin GM; Abbar M; Schlaepfer TE; Grunze H; Licht RW; Bellivier F; Fountoulakis KN; Altamura AC; Pitchot W; Ågren H; Holsboer-Trachsler E; Vieta E
    Curr Med Res Opin; 2011 Dec; 27(12):2285-99. PubMed ID: 22014287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
    Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K
    J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole.
    Raja M
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):107-10. PubMed ID: 16487453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole: new indication. Treatment and prevention of manic episodes: just another neuroleptic.
    Prescrire Int; 2009 Jun; 18(101):117. PubMed ID: 19637429
    [No Abstract]   [Full Text] [Related]  

  • 12. Aripiprazole-induced sialorrhea.
    Praharaj SK; Jana AK; Sinha VK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):384-5. PubMed ID: 19162120
    [No Abstract]   [Full Text] [Related]  

  • 13. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
    Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
    J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priapism associated with oxcarbazepine, aripiprazole, and lithium.
    Negin B; Murphy TK
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223-4. PubMed ID: 16292111
    [No Abstract]   [Full Text] [Related]  

  • 16. Aripiprazole for the treatment of bipolar disorder: a review of current evidence.
    Fagiolini A; Nitti M; Forgione RN; Marra FS; Casamassima F
    Expert Opin Pharmacother; 2011 Feb; 12(3):473-88. PubMed ID: 21254952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole: a review of its use in the treatment of manic episodes in adolescents with bipolar I disorder.
    McKeage K
    CNS Drugs; 2014 Feb; 28(2):171-83. PubMed ID: 24399490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three cases of hypomania and one case of mania during aripiprazole treatment.
    Viikki M; Valtonen HM; Leinonen E
    Pharmacopsychiatry; 2011 Mar; 44(2):78-81. PubMed ID: 21157696
    [No Abstract]   [Full Text] [Related]  

  • 19. A UK consensus on the administration of aripiprazole for the treatment of mania.
    Aitchison KJ; Bienroth M; Cookson J; Gray R; Haddad PM; Moore B; Ratna L; Sullivan G; Taylor D; Taylor M; Goodwin GM
    J Psychopharmacol; 2009 May; 23(3):231-40. PubMed ID: 19010974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
    Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
    J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.